Month: April 2022

News Alert

Merck Extends its Conditions on 340B Pricing Involving Contract Pharmacies to Health Centers

In News Alert, Pharma IndustryApril 28, 20221655 Views

Merck extended its restrictions on 340B pricing involving contract pharmacies to community health centers.

Drug manufacturer Merck today extended its restrictions on 340B pricing involving contract pharmacies to community health centers. The restrictions have applied only to hospital covered entities until now.

Other grantee covered entities remain exempt “at this time,” Merck

…

340B Report Holding May 18 Webinar on Implementing Drug Makers’ New 340B Contract Pharmacy Rules

In Pharma IndustryApril 28, 2022499 Views

Tom Mirga

Multiple 340B covered entities and consultants say they have hit roadblocks trying to navigate drug manufacturers restrictions on 340B pricing when entities contract with outside pharmacies to dispense 340B drugs.

340B Report, an independent news organization covering the 340B drug pricing program, is holding its first event—a May 18 webinar about implementing drug manufacturers’ controversial new rules on 340B contract pharmacies. It is an exclusive

…

Providers Alarmed About 45-Day Lookback Clauses in Drug Makers’ 340B Contract Pharmacy Policies

In Pharma IndustryApril 28, 2022754 Views

Tom Mirga

Covered entities are concerned about 45-day time limits for claims submissions and replenishment orders in drug manufacturers' 340B contract pharmacy policies.

Drug manufacturer Sanofi drew attention this month when it added 45-day time limits for replenishment orders and claims submissions to its conditions on 340B pricing when covered entities use contract pharmacies.

Pfizer and Amgen also recently added similar 45-day

…

How 340B Works for People Living with HIV

In Sponsored ContentApril 28, 20221125 Views

HIV/AIDS Clinics Tell FTC that PBMs Usurp 340B Discounts for Themselves

In Federal, RegulatoryApril 28, 2022247 Views

Tom Mirga

The "Man Controlling Trade" statute outside the FTC's Washington, D.C., headquarters. HIV/AIDS clinics recently submitted comments to the commission about PBMs' business practices.

Pharmacy benefit managers (PBMs) should be stopped from usurping 340B drug discounts from HIV/AIDS clinics and other safety-net providers, Ryan White Clinics for 340B Access (RWC-340B) told the U.S. Federal Trade Commission (FTC) last week.

RWC-340B asked the

…

Notable Mis-Quotables: Setting Organizational Policy When the Statute is Silent

In Sponsored ContentApril 28, 20221268 Views

With Retired Sen. Hatch’s Passing, a Legendary 340B Tale is Told

In Federal, LegislativeApril 26, 2022615 Views

Tom Mirga

Retired U.S. Sen. Orrin Hatch (R-Utah), who died this weekend, played a key role in 340B's creation and development.

Retired U.S. Sen. Orrin Hatch of Utah, a conservative Republican icon who helped create and shape the 340B drug pricing program, has died. He was 88.

Hatch personally was responsible for choosing one of the 340B program’s most

…

Federal Circuit Court Begins Lilly’s 340B Contract Pharmacy Lawsuit Appeal in Earnest

In Federal, JudicialApril 26, 2022469 Views

Tom Mirga

The U.S. Seventh Circuit Court of Appeals issued a schedule for the filing of briefs in Lilly's 340B contract pharmacy lawsuit.

A federal appeals court in Chicago is satisfied with the final judgement it ordered a lower court to issue in Lilly’s 340B contract pharmacy lawsuit, clearing the way the lawsuit’s next stage to get rolling.

The U.S. Seventh

…

Influential HIV/AIDS Group Asks Gilead to Exempt Ryan White Clinics from Company’s 340B Contract Pharmacy Restrictions

In Pharma Industry, Trade AssociationApril 26, 2022320 Views

Tom Mirga

RWC-340B asked Gilead to exempt all Ryan White clinics from the company’s conditions on 340B pricing on its branded hepatitis C treatments when covered entities use contract pharmacies.

Ryan White Clinics for 340B Access (RWC-340B) has asked drug manufacturer Gilead to exempt all Ryan White clinics from the company’s conditions on 340B pricing on its branded hepatitis C treatments when covered entities use contract pharmacies.

RWC-340B

…

73 Groups Want Congress to Enact Major Drug Pricing Reforms by Memorial Day

In Federal, LegislativeApril 26, 2022250 Views

Tom Mirga

Seventy three organizations, under the banner Push for LowerRx Prices, launched a campaign to press Congress to pass comprehensive Democratic drug pricing legislation by Memorial Day.

More than 70 groups representing patients, healthcare professionals, consumers, retirees, employers, and unions launched a campaign this morning to get comprehensive Democratic drug pricing legislation signed into law by Memorial Day.

It is premature to guess how the

…